What's more, many properly founded adverse prognostic markers, together with U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, missing their unfavorable effect in individuals handled with VO. The one component that remained predictive of a shorter progression-free of charge survival On this cohort of people was TP53 aberrations.112 Eventually, the